I-Mab Biopharma
IMAB
#9469
Rank
A$91.66 M
Marketcap
$1.12
Share price
-6.87%
Change (1 day)
-58.84%
Change (1 year)

EPS for I-Mab Biopharma (IMAB)

EPS in 2020 (TTM): $1.57

According to I-Mab Biopharma's latest financial reports the company's current EPS (TTM) is $2.28. In 2021 the company made an earnings per share (EPS) of -$7.97 a decrease over its 2020 EPS that were of $2.05.

EPS history for I-Mab Biopharma from 2017 to 2020

Annual EPS

Year EPS Change
2021-$7.97-489.3%
2020$2.05-133.67%
2019-$6.08179.42%
2018-$2.1827.77%
2017-$1.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.65-172.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.45-119.61%๐Ÿ‡บ๐Ÿ‡ธ USA